Vergoeding 2015-2019 voor ATC-subgroep N06AA : Niet-selectieve monoamine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| N06AA02 Imipramine | 197.220 | 195.350 | 169.890 | 145.930 | 141.220 |
| N06AA04 Clomipramine | 1.314.800 | 1.153.600 | 1.115.500 | 1.135.900 | 1.155.800 |
| N06AA09 Amitriptyline | 2.216.500 | 2.133.200 | 2.094.100 | 2.343.600 | 2.797.700 |
| N06AA10 Nortriptyline (Nortrilen ®) | 3.385.700 | 3.546.500 | 3.684.300 | 3.847.000 | 3.749.600 |
| N06AA12 Doxepine (Sinequan ®) | 104.220 | 102.310 | 95.050 | 91.149 | 82.660 |
| N06AA16 Dosulepine (Prothiaden ®) | 65.482 | 63.605 | 54.097 | 47.039 | 45.763 |
| N06AA21 Maprotiline | 77.747 | 71.845 | 64.799 | 60.317 | 50.238 |
| Totaal | 7.361.669 | 7.266.410 | 7.277.736 | 7.670.935 | 8.022.981 |